Behind the scenes with Dream Team, CytRx and Galena (Moxreports, Mar. 12, 2014)
SEC: Payments for Bullish Articles on Stocks Must Be Disclosed to Investors (Apr. 10, 2017)
SEC Complaint: Lidingo Holdings, et al. (Apr. 10, 2017)
SEC Complaint: CSIR, et al. (Apr. 10, 2017)
SEC Order: Ciaran Thornton (Apr. 10, 2017)
SEC Order: Michael McCarthy, DreamTeam Group, Mission Investor Relations, et al. (Apr. 10, 2017)
SEC Order: Stephen Ramey (Apr. 10, 2017)
SEC Order: Edward Borrelli and Dunedin Inc. (Apr. 10, 2017)
SEC Order: Joel Corenman (Apr. 10, 2017)
SEC Order: Galena Biopharma and Mark Ahn (Apr. 10, 2017)
SEC Order: ImmunoCellular Therapeutics Ltd. (Apr. 10, 2017)
SEC Order: Craig Keolanui (Apr. 10, 2017)
SEC Order: Lion Biotechnologies (Apr. 10, 2017)
SEC Order: Manish Singh and Lavos LLC (Apr. 10, 2017)
SEC Order: Christopher French (Apr. 10, 2017)
Short FNRG. Undisclosed Promotions And Management Connections To Past Frauds (Moxreports, Apr. 15, 2015)
DOJ: Chairman Of The Board Of Forcefield Energy Inc. Arrested For Securities Fraud Conspiracy (Apr. 20, 2015)
FBI: Chairman of the Board of Forcefield Energy Inc. Arrested for Securities Fraud Conspiracy (Apr. 20, 2015)
SEC Suspension of Trading (SEC, Apr. 21, 2015)
SEC and Law Enforcement Partners Crack Stock Promotion and Kickback Schemes (SEC, May 3, 2016)
SEC Complaint: Richard St. Julien, et al.(May 3, 2016)
DOJ: Stock Promoter Convicted In $131 Million Market Manipulation Scheme (May 2, 2017)
DOJ: Registered Broker Sentenced To 18 Months In Prison For Securities Fraud In A $131 Million Market Manipulation Scheme (Jul. 7, 2017)
DOJ: Former Registered Broker Sentenced To 15 Months In Prison For Securities Fraud In A $131 Million Market Manipulation Scheme (Aug. 9, 2017)
SEC Administrative Proceedings: Brian C. Jensen (Sep. 27, 2017)
SEC Charges Accountant with Defrauding Investors Through Kickback Scheme (SEC, Sep 29, 2017)
DOJ: New York Investment Adviser Convicted of Defrauding Investors (Mar. 9, 2018)
Osiris: Aggressive Channel Stuffing, Accounting Irregularities Or Outright Fraud? (Moxreports, Jan. 15, 2016)
Short OSIR. Osiris Therapeutics Beset By Newer And Bigger Troubles (Moxreports, Mar. 24, 2016)
Short OSIR. After Criminal Investigation, Osiris Is Finally Delisted (Moxreports, Mar. 13, 2017)
SEC Form 8-K: Osiris auditor resignation (Dec. 11, 2015)
SEC Form 8-K: CEO Debrabandere forced to resign (Feb. 3, 2016)
Osiris Receives Notice of Delisting from NASDAQ (Osiris, Mar. 10, 2017)
Osiris Therapeutics, Inc. Completes Restatement for 2014 Financial Statements (Osiris, Mar 27, 2017)
SEC Charges Biotech Company, Executives With Accounting Fraud (Nov. 2, 2017)
SEC Complaint: Osiris Therapeutics, Inc., et al. (Nov. 2, 2017)
Former Chief Financial Officer Of Osiris Therapeutics, Inc., Pleads Guilty To Lying To Auditors (Nov. 2, 2017)
Short UNXL. As Unipixel Plunges, MDB Capital Pulls Research (Moxreports, Jan 25, 2013)
Uni-Pixel Drops 12%: CEO Killion Steps Down, Chair Marren to Take Over (Dec. 31, 2013)
SEC Deferred Prosecution Agreement against Chairman Bernard T. Marren (Mar. 3, 2016)
SEC: Tech Company Misled Investors About Key Product (Mar. 9, 2016)
SEC Complaint: Reed J. Killion, Jeffrey W. Tomz, and Uni-Pixel, Inc. (Mar. 9, 2016)
Former Executives of Tech Company Agree to Pay Penalties to Settle SEC Action (Mar. 9, 2016)
Uni-Pixel Plunges 69%: Going Bankrupt, All Employees Let Go (Aug. 25, 2017)
SEC Order: Jeffrey W. Tomz, CPA (Oct. 19, 2017)
Short UNIS. The Big Picture At Unilife (Moxreports, Dec. 9, 2013)
Behind The Scenes With Proactive, Inovio and Unilife (Moxreports, Mar. 27, 2014)
SEC Form 8-K: Chairman Bosnjak resigns (Aug. 24, 2015)
SEC Form 8-K: CEO Shortall & COO Mojdeh forced to resign (Mar. 11, 2016)
Unilife Files for Chapter 11 Protection (Unilife, Apr. 12, 2017)
SEC Order: Alan Shortall (Dec. 22, 2017)
Unilife founder Alan Shortall cops ban from US Securities watchdog (The Sydney Morning Herald, Feb. 12, 2018)
Short NWBO. Behind The Promotion Of Northwest Bio (Moxreports, Jun 7, 2014)
Northwest Biotherapeutics to probe allegations of poor governance (The Washington Post, Dec. 1, 2015)
SEC Form 8-K: Nasdaq delisting (Dec. 7, 2016)
SEC Form 10-K: NWBO SEC subpoena and investigation revealed (Apr 17, 2017)
Northwest Bio Receives SEC Subpoena and Other Awful Nuggets From New 10-K (The Street, Apr. 18, 2017)
Short ARA. JV Partners Rushing To Sell Equity Stakes. But Why? (Moxreports, Jul. 10, 2017)
SEC Form 8-K: ARA receives subpoena from the U.S. Department of Justice (Jan 3, 2017)
American Renal Associates Holdings, Inc. Announces Delay in Release of Fourth Quarter and Year-End 2018 Earnings, Filing of 2018 10-K (American Renal Associates, Mar. 8, 2019)
SEC Form 8-K: Non-reliance on previously issued financial statements, CFO resignation (Mar. 27, 2019)
American Renal Associates to Restate Financial Results, CFO Departs (The Wall Street Journal, Mar. 27, 2019)
American Renal Associates Receives an SEC Subpoena; Block & Leviton LLP Encourages Shareholders to Contact the Firm (Associated Press, Mar. 30, 2019)